19
Views
20
CrossRef citations to date
0
Altmetric
Original Article

Antiphospholipid Antibodies: A New Risk Factor for Restenosis After Percutaneous Transluminal Coronary Angioplasty?

, , , , , , , , , , & show all
Pages 141-148 | Received 03 Mar 1997, Accepted 21 Jul 1997, Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ana Rodríguez-Sanz, Patricia Martínez-Sánchez, Daniel Prefasi, Blanca Fuentes, Dora Pascual-Salcedo, María Jesús Blanco-Bañares & Exuperio Díez-Tejedor. (2015) Antiphospholipid antibodies correlate with stroke severity and outcome in patients with antiphospholipid syndrome. Autoimmunity 48:5, pages 275-281.
Read now
Alessandro Farsi, Maria Paola Domeneghetti, Sandra Fedi, Monia Capanni, Betti Giusti, Rossella Marcucci, Letizia Giurlani, Domenico Prisco, Angelo Passaleva, Gian Franco Gensini & Rosanna Abbate. (1999) High Prevalence of Anti-β2 Glycoprotein I Antibodies in Patients with Ischemic Heart Disease. Autoimmunity 30:2, pages 93-98.
Read now

Articles from other publishers (18)

Guodong Ma, Huiqiang Zhao, Yutong Fei, Aidong Shen, Hui Chen & Hongwei Li. (2019) Autoimmune Diseases May Increase Adverse Cardiovascular Events After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis. Heart, Lung and Circulation 28:10, pages 1510-1524.
Crossref
Daniele Pastori, Tommaso Bucci, Massimo Triggiani, Paul R.J. Ames, Sandro Parrotto, Francesco Violi, Pasquale Pignatelli & Alessio Farcomeni. (2019) Immunoglobulin G (IgG) anticardiolipin antibodies and recurrent cardiovascular events. A systematic review and Bayesian meta-regression analysis. Autoimmunity Reviews 18:5, pages 519-525.
Crossref
Mauricio Mora-Ramirez, Héctor Gonzalez-Pacheco & Luis M. Amezcua-Guerra. (2018) The Impact of Primary Antiphospholipid Syndrome on Long-term Cardiovascular Outcomes After Percutaneous Coronary Intervention and Stenting in Patients With Myocardial Infarction. JCR: Journal of Clinical Rheumatology 24:3, pages 169-173.
Crossref
Pravesh Kumar Bundhun, Kamini Devi Boodhoo, Man-Yun Long & Meng-Hua Chen. (2016) Impact of Antiphospholipid Syndrome and/or Systemic Lupus Erythematosus on the Long-term Adverse Cardiovascular Outcomes in Patients After Percutaneous Coronary Intervention. Medicine 95:12, pages e3200.
Crossref
You-Hong LeeHyoung-Mo YangSeung-Jea TahkYou-Sun HongJin-Sun ParkKyoung-Woo SeoYong-Woo ChoiChoong-Kyun Noh. (2015) Recurrent Stent Thrombosis in a Patient with Antiphospholipid Syndrome and Dual Anti-Platelet Therapy Non-Responsiveness. Korean Circulation Journal 45:1, pages 71.
Crossref
Jacob H. Rand & Lucia R. Wolgast. 2013. Consultative Hemostasis and Thrombosis. Consultative Hemostasis and Thrombosis 324 341 .
John R. Bartholomew. 2013. Perioperative Management of Patients with Rheumatic Disease. Perioperative Management of Patients with Rheumatic Disease 109 127 .
Ioanna Koniari, Stavros N. Siminelakis, Nikolaos G. Baikoussis, Georgios Papadopoulos, John Goudevenos & Efstratios Apostolakis. (2010) Antiphospholipid syndrome; its implication in cardiovascular diseases: a review. Journal of Cardiothoracic Surgery 5:1.
Crossref
William F. BakerJr.Jr. & Rodger L. Bick. (2008) The Clinical Spectrum of Antiphospholipid Syndrome. Hematology/Oncology Clinics of North America 22:1, pages 33-52.
Crossref
T. P. GRECO, A. M. CONTI-KELLY, E. MATSUURA, T. GRECO, K. J. DIER, G. SVANAS, R. DOYLE & L. R. LOPEZ. (2007) Antiphospholipid Antibodies in Patients with Coronary Artery Disease: New Cardiac Risk Factors?. Annals of the New York Academy of Sciences 1108:1, pages 466-474.
Crossref
Josep Font & Ricard Cervera. 2006. Hughes Syndrome. Hughes Syndrome 41 52 .
Adalet Gürlek, Çagdas Özdöl, Gülgün Pamir, Irem Dinçer, Hüseyin Tutkak & Dervis Oral. (2005) Association Between Anticardiolipin Antibodies and Recurrent Cardiac Events in Patients With Acute Coronary Syndrome. International Heart Journal 46:4, pages 631-638.
Crossref
Alexander Niessner, Stephan Hornykewycz, Senta Graf, Mariam Nikfardjam, Walter S Speidl, Peter Probst, Gerlinde Zorn, Gerald Maurer, Johann Wojta & Kurt Huber. (2004) Pre-existing anticardiolipin antibodies and development of restenosis after coronary balloon angioplasty. Blood Coagulation & Fibrinolysis 15:4, pages 311-316.
Crossref
Ricard Cervera. (2004) Coronary and valvular syndromes and antiphospholipid antibodies. Thrombosis Research 114:5-6, pages 501-507.
Crossref
Sefer Gezer. (2003) Antiphospholipid syndrome. Disease-a-Month 49:12, pages 696-741.
Crossref
Gerard Espinosa, Ricard Cervera, Josep Font, Mario García-Carrasco, Carlos Battagliotti & Miguel Ingelmo. 2002. The Antiphospholipid Syndrome II. The Antiphospholipid Syndrome II 169 188 .
Robin L Brey. (2000) Differential Diagnosis of Central Nervous System Manifestations of the Antiphospholipid Antibody Syndrome. Journal of Autoimmunity 15:2, pages 133-138.
Crossref
Charles J. Glueck, James E. Lang, Trent Tracy, Luann Sieve-Smith & Ping Wang. (1999) Evidence that anticardiolipin antibodies are independent risk factors for atherosclerotic vascular disease. The American Journal of Cardiology 83:10, pages 1490-1494.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.